<H1>Chapter DOI: 10.1007/s10047-008-0436-1<br/>Cited-By Count: 7</H1><table border="1" width="30%"><tr><td>Total References</td><td>23</td></tr><tr><td>Springer references</td><td>2</td></tr><tr><td>Non Springer references</td><td>21</td></tr><tr><td>BibStructured Count</td><td width="10%">23</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>16</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>2</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>2</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Boyce TB. Design principles for composition and performance of cultured skin substitutes. Burns 2001;27:523&#8211;533</td><td><a href=http://dx.doi.org/10.1016/S0305-4179(01)00019-5>10.1016/S0305-4179(01)00019-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Kubo K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelocollagen combined with fibroblasts: fundamental evaluation. J Biomater Sci Polymer Edn 2003;14:625&#8211;641</td><td><a href=http://dx.doi.org/10.1163/156856203322274897>10.1163/156856203322274897</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Kubo K, Kuroyanagi Y. Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test. J Artif Organs 2003;6:64&#8211;70</td><td><a href=http://dx.doi.org/10.1007/s100470300010>10.1007/s100470300010</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Kubo K, Kuroyanagi Y. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organs 2003;6:138&#8211;144</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Kubo K, Kuroyanagi Y. Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro. J Artif Organs 2003;6:267&#8211;272</td><td><a href=http://dx.doi.org/10.1007/s10047-003-0239-3>10.1007/s10047-003-0239-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Kuroyanagi Y, Kubo K, Matsui H, Kim HJ, Numari S, Mabuchi Y, Kagawa S. Establishment of banking system for allogeneic cultured dermal substitute. Artif Organs 2004;28:13&#8211;21</td><td><a href=http://dx.doi.org/10.1111/j.1525-1594.2004.07318.x>10.1111/j.1525-1594.2004.07318.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Kubo, K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelocollagen combined with fibroblasts: cryopreservation. Artif Organs 2004;28:182&#8211;188</td><td><a href=http://dx.doi.org/10.1111/j.1525-1594.2004.47219.x>10.1111/j.1525-1594.2004.47219.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Kubo K, Kuroyanagi Y. The possibility of long-term cryopreservation of cultured dermal subsitute. Artif Organs 2005;29:800&#8211;805</td><td><a href=http://dx.doi.org/10.1111/j.1525-1594.2005.00132.x>10.1111/j.1525-1594.2005.00132.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Kubo K, Kuroyanagi Y. A study of cytokines released from fibroblasts in cultured dermal subsitute. Artif Organs 2005;29:845&#8211;849</td><td><a href=http://dx.doi.org/10.1111/j.1525-1594.2005.00138.x>10.1111/j.1525-1594.2005.00138.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Kashiwa N, Ito O, Ueda T, Kubo K, Matsui H, Kuroyanagi Y. Treatment of full-thickness skin defect with concomitant grafting of sixfold extended mesh auto-skin and allogeneic cultured dermal substitute. Artif Organs 2004;28:444&#8211;450</td><td><a href=http://dx.doi.org/10.1111/j.1525-1594.2004.00009.x>10.1111/j.1525-1594.2004.00009.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Ohtani T, Okamoto K, Kaminaka C, Kishi T, Sakurane M, Yamamoto Y, Ueda K, Kubo K, Kuroyanagi Y, Furukawa F. Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS). Eur J Dermatol 2004;14:168&#8211;171</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Moroi Y, Fujita S, Fukagawa S, Mashino T, Goto T, Masuda T, Urabe K, Kubo K, Matsui H, Kagawa S, Kuroyanagi Y, Furue M. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection. Eur J Dermatol 2004;14:172&#8211;176</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Hasegawa T, Suga Y, Mizoguchi M, Ikeda S, Ogawa H, Kubo K, Matsui H, Kagawa S, Kuroyanagi Y. Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in three patients with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol 2004;50:803&#8211;804</td><td><a href=http://dx.doi.org/10.1016/j.jaad.2003.08.013>10.1016/j.jaad.2003.08.013</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Hasegawa T, Suga Y, Mizoguchi M, Muramatsu S, Minuzo Y, Ogawa H, Kubo K, Kuroyanagi Y. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports. J Dermatol 2005;32:715&#8211;720</td><td><a href=http://dx.doi.org/10.1111/j.1346-8138.2005.tb00831.x>10.1111/j.1346-8138.2005.tb00831.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Year, ArticleTitle, FirstPage, VolumeID, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Hasegawa T, Suga Y, Mizoguchi M, Muramatsu S, Mizuno Y, Ikeda S, Haruna K, Kuroyanagi Y, Ogawa H. A case of intractable venous leg ulcer treated successfully with allogeneic cultured dermal substitute. Scand J Plast Reconstr Surg Hand Surg 2007;41:326&#8211;328</td><td><a href=http://dx.doi.org/10.1080/02844310600723224>10.1080/02844310600723224</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Yonezawa M, Tanizaki H, Inoguchi N, Ishida M, Katoh M, Tachibana T, Miyachi Y, Kubo K, Kuroyanagi Y. Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers. Int J Dermatol 2007;46:36&#8211;42</td><td><a href=http://dx.doi.org/10.1111/j.1365-4632.2007.03107.x>10.1111/j.1365-4632.2007.03107.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Nishimoto J, Amoh Y, Tanabe K, Niiyama N, Katsuoka K, Kuroyanagi Y. Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with allogeneic cultured dermal substitute. Eur J Dermatol 2007;17:350&#8211;351</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Dijke P, Iwata KK. Growth factors for wound healing. Biotechnology 1989;7:793&#8211;798</td><td><a href=http://dx.doi.org/10.1038/nbt0889-793>10.1038/nbt0889-793</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Falanga V. Growth factors and wound healing. J Dermatol Surg Oncol 1993;19:711&#8211;714</td><td><a href=http://dx.doi.org/10.1111/j.1524-4725.1993.tb00414.x>10.1111/j.1524-4725.1993.tb00414.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, VolumeID, Author_FamilyName_1, Year, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Moulin V. Growth factor in skin wound healing. Eur J Cell Biology 1995;68:1&#8211;7</td><td><a href=http://dx.doi.org/10.1016/S0006-3495(95)80233-X>10.1016/S0006-3495(95)80233-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445&#8211;1452</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Corral CJ, Siddiqui A, Wu L, Farrell CL, Lyons D, Mustoe TA. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg 1999;134:200&#8211;205</td><td><a href=http://dx.doi.org/10.1001/archsurg.134.2.200>10.1001/archsurg.134.2.200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Nayeri F, Stromberg T, Larsson M, Brudin L, Soderstrom C, Forsberg P. Hepatocyte growth factor may accelerate healing in chronic leg ulcers: pilot study. J Dermatol Treat 2002;13:81&#8211;86</td><td><a href=http://dx.doi.org/10.1080/095466302317584449>10.1080/095466302317584449</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>